WERNER ROBERT F. 4

What Happened

• Robert F. Werner, Chief Accounting Officer of Twist Bioscience (TWST), reported sales of a total of 7,175 shares in early February 2026, generating roughly $327,687.
• Transactions: 175 shares sold on 2026-02-03 at $46.58 each ($8,151) and 7,000 shares sold on 2026-02-04 at $45.65 each ($319,536). Both sales are reported as disposals (code S).

Key Details

• Dates and prices:
  • 2026-02-03: 175 shares @ $46.58 = $8,151.
  • 2026-02-04: 7,000 shares @ $45.65 = $319,536.
  • Footnote F2: weighted average sales price and range noted; sales prices ranged $45.61–$45.78; detailed per-price breakdown available upon request.
• Reason/footnote: Footnote F1 states these sales represent shares sold to satisfy tax withholding obligations tied to RSU vesting ("sell-to-cover") and are not discretionary trades by the reporting person.
• Shares owned after the transactions: not specified in the provided excerpt of the filing.
• Timeliness: Form 4 was filed on 2026-02-05; based on the report dates (Feb 3–4) the filing appears timely.

Context

• These reported sales were primarily sell-to-cover transactions for tax withholding related to equity vesting, which are routine and do not necessarily reflect the insider’s view on the company. No purchases or option exercises were reported in this filing.